Highland Transcend Partners I Corp. (NYSE:HTPA) announced this afternoon that it has mutually terminated its combination with ecommerce service provider Packable.
As with other recent terminations, the parties cited “current unfavorable market conditions” as the cause of the breakup.
However, the SPAC is still required to hold its shareholder’s meeting on Tuesday, March 29. Although this meeting’s purpose was to vote on the business combination, HTP intends to present the Adjournment Proposal instead. If approved, the special meeting will be adjourned indefinitely in accordance with Cayman Islands law and the terms of HTP. Any shareholders who submitted redemptions will have the opportunity to withdraw it any time by notifying HTP’s transfer agent.
The current market pain is raining down on SPACs and IPOs alike, making Highland Transcend’s deal the 15th to terminate this year. For now, the SPAC is considering its options in the disruptive commerce, digital media and services, and enterprise software sectors, and still has some time left with a termination deadline set for December 2022.
The parties originally announced the $1.55 billion combination last year on September 9. Hauppauge, New York-based Packable operates the ecommerce platform Pharmapacks and serves consumer brands in managing their own ecommerce optimization and fulfillment in other marketplaces.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...